Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Stage-Dependent Efficacy of TACE Combined with Tyrosine Kinase and Immune Checkpoint Inhibitors as Conversion Therapy for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

Saved in:
Bibliographic Details
Published in:Journal of Hepatocellular Carcinoma
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1871475375917236224
collection WordPress RSS
FRELIP Feed Integration
container_title Journal of Hepatocellular Carcinoma
description
discipline_display Communicable Diseases, Epidemiology
discipline_facet Communicable Diseases, Epidemiology
format Online Article
RSS Article
genre Journal Article
id rss_article:105462
institution FRELIP
journal_source_facet Journal of Hepatocellular Carcinoma
last_indexed 2026-07-23T03:39:59.775Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Stage-Dependent Efficacy of TACE Combined with Tyrosine Kinase and Immune Checkpoint Inhibitors as Conversion Therapy for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
sub_discipline_display General
sub_discipline_facet General
subject_display Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
subject_facet Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
title Stage-Dependent Efficacy of TACE Combined with Tyrosine Kinase and Immune Checkpoint Inhibitors as Conversion Therapy for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
title_alt Eficacia dependiente del estadio de TACE combinado con inhibidores de tirosina quinasa y puntos de control inmunitario como terapia de conversión para el carcinoma hepatocelular no resecable: Un estudio retrospectivo multicéntrico
Efficacité de la TACE combinée aux inhibiteurs de tyrosine kinase et aux inhibiteurs de points de contrôle immunitaires en fonction du stade comme thérapie de conversion pour le carcinome hépatocellulaire non résécable : une étude rétrospective multicentrique
Eficácia Dependente do Estádio da TACE Combinada com Inibidores de Tirosina Quinase e Checkpoint Imune como Terapia de Conversão para Carcinoma Hepatocelular Irressecável: Um Estudo Retrospectivo Multicêntrico
title_auth Stage-Dependent Efficacy of TACE Combined with Tyrosine Kinase and Immune Checkpoint Inhibitors as Conversion Therapy for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
title_es_txt Eficacia dependiente del estadio de TACE combinado con inhibidores de tirosina quinasa y puntos de control inmunitario como terapia de conversión para el carcinoma hepatocelular no resecable: Un estudio retrospectivo multicéntrico
title_fr_txt Efficacité de la TACE combinée aux inhibiteurs de tyrosine kinase et aux inhibiteurs de points de contrôle immunitaires en fonction du stade comme thérapie de conversion pour le carcinome hépatocellulaire non résécable : une étude rétrospective multicentrique
title_full Stage-Dependent Efficacy of TACE Combined with Tyrosine Kinase and Immune Checkpoint Inhibitors as Conversion Therapy for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
title_fullStr Stage-Dependent Efficacy of TACE Combined with Tyrosine Kinase and Immune Checkpoint Inhibitors as Conversion Therapy for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
title_full_unstemmed Stage-Dependent Efficacy of TACE Combined with Tyrosine Kinase and Immune Checkpoint Inhibitors as Conversion Therapy for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
title_pt_txt Eficácia Dependente do Estádio da TACE Combinada com Inibidores de Tirosina Quinase e Checkpoint Imune como Terapia de Conversão para Carcinoma Hepatocelular Irressecável: Um Estudo Retrospectivo Multicêntrico
title_short Stage-Dependent Efficacy of TACE Combined with Tyrosine Kinase and Immune Checkpoint Inhibitors as Conversion Therapy for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
title_sort stage-dependent efficacy of tace combined with tyrosine kinase and immune checkpoint inhibitors as conversion therapy for unresectable hepatocellular carcinoma: a multicenter retrospective study
topic Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
url https://www.dovepress.com/stage-dependent-efficacy-of-tace-combined-with-tyrosine-kinase-and-imm-peer-reviewed-fulltext-article-JHC